Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

The treatment promoted hair growth safely and effectively.

Scalp cooling can help prevent hair loss during chemotherapy.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Low-dose oral naltrexone may help reduce inflammation in some scarring alopecia patients.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

Freezing nitrogen ethanol composite is safer than liquid nitrogen for treating musculoskeletal tumors.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

TS-13 speeds up hair regrowth after chemotherapy without affecting treatment effectiveness.

A new mutation in the mitochondrial DNA was found in a boy with MELAS, even though his family didn't show typical signs.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The 308-nm Excimer laser is effective and safe for treating patchy alopecia areata in children.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Chemotherapy and radiotherapy improved quality of life and reduced symptoms in lung cancer patients.

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Combining PRP with follicular transplantation improves vitiligo treatment better than follicular transplantation alone.

IL-27 may help prevent hair loss in alopecia areata by promoting immunosuppressive T cells.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Low-level laser therapy is the most supported non-drug treatment for hair loss, but combining it with other methods may be promising.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.